Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

MDXG

MIMEDX GROUP, INC.

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 1376339Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$419.0M
Net Income FY2025
$49.0M
EPS (Basic, as reported)
$0.33
Net Margin FY2025
11.6%
ROE FY2025
18.9%
Total Equity
$257.0M
Shares Out
146M
Business description

MIMEDX GROUP, INC. — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2010–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 222 → 419 +7.3% CAGR
Revenue222321359299248259268321349419
Cost of revenue(31)(35)(36)(43)(39)(43)(48)(55)(60)(73)
Gross profit213286323256209215220267289346
Research & development(12)(18)(16)(11)(12)(17)(23)(13)(12)(15)
Selling, general & administrative(180)(220)(259)(198)(181)(198)(209)(211)(225)(266)
Selling & marketing——————(151)(162)(176)(210)
General & administrative——————(57)(49)(50)(57)
Operating income1846(4)(21)(45)(5)(25)375964
Interest expense0—————(5)(7)(4)(2)
Interest & investment income——————0035
Other income (expense), net00000000(1)(1)
Pre-tax income1845(3)(26)(62)(10)(30)315766
Income tax expense(6)(20)(27)0(12)00(37)(15)(18)
Net income1265(30)(26)(49)(10)(30)584249
EPS — basic$0.00$0.61($0.28)($0.24)($0.77)($0.15)($0.33)$0.40$0.29$0.33
EPS — diluted$0.00$0.56($0.28)($0.24)($0.77)($0.15)($0.33)$0.37$0.28$0.32
Shares outstanding — basic (M)106106106107108110113116147148
Shares outstanding — diluted (M)112116106107108110113146149150

Showing the latest 10 of 16 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.